Your browser doesn't support javascript.
loading
[Acquired hemophilia A following BNT162b2 mRNA COVID-19 vaccination].
Senda, Ayami; Saito, Hideaki; Kusakabe, Shinsuke; Yoshida, Koki; Shibata, Kumi; Kida, Shuhei; Toda, Jun; Hino, Akihisa; Ueda, Tomoaki; Fujita, Jiro; Fukushima, Kentaro; Yokota, Takafumi; Kashiwagi, Hirokazu; Hosen, Naoki.
Afiliación
  • Senda A; Department of Hematology and Oncology, Osaka University.
  • Saito H; Department of Hematology and Oncology, Osaka University.
  • Kusakabe S; Department of Hematology, Daini Osaka Police Hospital.
  • Yoshida K; Department of Hematology and Oncology, Osaka University.
  • Shibata K; Department of Hematology and Oncology, Osaka University.
  • Kida S; Department of Hematology and Oncology, Osaka University.
  • Toda J; Department of Hematology and Oncology, Osaka University.
  • Hino A; Department of Hematology and Oncology, Osaka University.
  • Ueda T; Department of Hematology, National Hospital Organization Osaka National Hospital.
  • Fujita J; Department of Hematology and Oncology, Osaka University.
  • Fukushima K; Department of Hematology and Oncology, Osaka University.
  • Yokota T; Department of Hematology and Oncology, Osaka University.
  • Kashiwagi H; Department of Hematology and Oncology, Osaka University.
  • Hosen N; Department of Hematology and Oncology, Osaka University.
Rinsho Ketsueki ; 64(1): 35-41, 2023.
Article en Ja | MEDLINE | ID: mdl-36775305

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 / Hemofilia A Límite: Aged80 / Female / Humans Idioma: Ja Revista: Rinsho Ketsueki Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 / Hemofilia A Límite: Aged80 / Female / Humans Idioma: Ja Revista: Rinsho Ketsueki Año: 2023 Tipo del documento: Article